Multiple early-phase clinical programs have evaluated agents modulating these mechanisms, such as CCR2/CCL2 blockade (emapaticap pegol, CCX140-B) (Zhou et al., 2025b), IL-6 neutralization (ziltivekimab), and anti-fibrotic candidates like pirfenidone or ASK1 inhibition (selonsertib) (Petrovic et al., 2025) (Figure 6)
L., -32, , , -, , H
This stability window is comparable to [BPC-157]( and [Thymosin Beta-4]( but shorter than highly stable peptides like [Epithalon]( which can maintain potency for 60+ days post-reconstitution
This temperature range is critical for maintaining the structural integrity of the peptide molecules within the medication
all changes must be discussed with and approved by their prescribing clinician, who will consider the full clinical picture including renal function, concurrent medications, and treatment goals
Aronne, MD, FACP is a world-renowned physician, researcher, professor, and leading expert in weight management and GLP-1 medications